Before the outbreak of the Covid-19, pandemic pharmaceutical companies was still using artificial intelligence and other Technologies to power their drug and vaccine production process.
Unfortunately, when coronavirus spearheaded it spread across all geographical regions, the government started running after potential vaccines. That was when the world realized the true potential of artificial intelligence;Big data,data analytics and many more technologies in pharmaceutical companies.
Technology help them figure out the right drug and vaccine and also accelerated the production process.
Vaccine Discovery and Manufacturing that usually takes 10 to 15 years was already in our hands within months.
Thanks to artificial intelligence.
In this article, we list some of the famous pharmaceutical companies that are using artificial intelligence in their routine medicine making process.
AstraZeneca
AstraZeneca is a global science led by a pharmaceutical business. The organization's inserting information science and man-made brainpower across its innovative work to empower its researchers to push the limits of science to convey extraordinary medications.
The company is integrating data science and artificial intelligence into its research and development to order to assist its scientists in pushing the boundaries of science and bringing about life-altering medicines.
AstraZeneca is using cognitive graphs and image analysis to gather new insights into diseases and identify biomarkers 30% faster than human pathologists.The company is also availing machine learning and chemistry automation to shorten the lengthy drug discovery process and cost by 75%.
Pfizer
Pfizer is one of the world's largest pharmaceutical companies. Throughout its vaccine process pfizer took help from artificial intelligence to make the covid-19 vaccine.
During vaccine trials, the organization utilized computer based intelligence programming to assist with finding signals inside the large numbers of data of interest in its 44,000-man study. Pfizer began digitizing its research and development processes and incorporating artificial intelligence into its operational system prior to the pandemic.
The pharmaceutical company and IBM Watson collaborated on drug discovery in 2016.
He recently became a friend of Pfizer. a tech company that designs virtual drugs to use its artificial intelligence for research.
NOVARTIS
Novartis is a global Healthcare come. It has taken revolutionary steps towards the implementation of artificial intelligence in its healthcare operations.
It collaborated with half A.I to develop a system that will be used to decode Cancer Pathology images through AI.
In June 2017, it joined hands with IBM Watson to use data analysis and machine learning to study the possible outcomes of different breast cancer treatments.
In January 2018, The company also partnered with MacKenzie's Quantum Black, to analyze 500 clinical trial operations worldwide.
In September 2019, Novartis announced a multi-year alliance with Microsoft that will leverage AI to transform the way new medicines were developed.
Johnson & Johnson
Johnson & Johnson is a multinational corporation that focuses on improving the state of personal health and hygiene.
The company introduced Andy and AI chat box that helps its users throughout the acuvue journey for those considering lenses for the first time to long-term wearers.
In January 2018, Jen chieh partnered with winter live labs, to try predicting dementia and neurodegenerative diseases through voice samples collected in the youngs and clinical trials.
In April 2019, the company collaborated with the AI driven drug designs startup Ictus, to use its technology on small molecule drug discovery projects.
GlaxoSmithKline
GlaxoSmithKline (GSK) is a multinational pharmaceutical company and is very active in implementing A.I for drug discovery. They have also created an in-house AI unit, called medicines discovered using artificial intelligence.
The company partnered with Google to create biomedical medicines that are implantable devices that can modify electrical signals running through the nerves and detects a regular impulses that occur due to any illness in the body.
GSK is also a member of a acceralating therapeutics for opportunities in medicine, Adam, Consortium, which aims to develop drug discovery from a slow sequential process to a rapid, integrated patient Centric model form.
Comments
Post a Comment